| Article ID | Journal | Published Year | Pages | File Type |
|---|---|---|---|---|
| 8448636 | European Journal of Cancer | 2008 | 9 Pages |
Abstract
The relative survival of RCC did not improve over the years. The resection rate in patients with metastasised disease did not increase over time, despite current knowledge concerning its benefit on tumour complications, time to progression and response to immunotherapy.
Related Topics
Life Sciences
Biochemistry, Genetics and Molecular Biology
Cancer Research
Authors
K.K.H. Aben, T.K. Luth, M.L.G. Janssen-Heijnen, P.F. Mulders, L.A. Kiemeney, D.J. van Spronsen,